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Abstract
[T]he purpose of my research is to analyze the efficiency of the US health care system through a panel data
analysis of the 19 OECD countries listed above (including the US) spanning the years 1990 to 2006 using an
Ordinary Least Squares (OLS) regression of a Cobb-Douglas production function. I intend to improve upon
previous estimates by utilizing the most recent data available, including better and more specific proxies for
certain variables, and only including countries whose performance is truly comparable to that of the US by
removing the low performing outliers that fall into a separate efficiency and income bracket of their own.
The format of my paper is as follows: Section II provides a review of previous literature on the topic of health
care system efficiency, Section III summarizes the theoretical model I employ in my research, Section IV
outlines my empirical model and data, Section V reports my results, Section VI offers a summation of my
findings and Section VII suggests potential venues for further research.
This article is available in The Park Place Economist: http://digitalcommons.iwu.edu/parkplace/vol18/iss1/8
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Do You Really Get What You Paid For? 
Analyzing the Productive Efficiency of U.S. Health Care 
 
AMANDA CLAYTON 
 
 
I. Introduction 
 
Recent health care policy reforms proposed by 
President Obama have prompted an increased 
interest in the efficiency of the US health care 
system. Looking at total health expenditure and life 
expectancy alone, the President has good reason to 
be hasty in his desire for change. Comparing the US 
to 18 other Organization of Economic Cooperation 
and Development (OECD) member countries at 
similar levels of development; namely: Austria, 
Australia, Belgium, Canada, Denmark, Finland, 
France, Germany, Greece, Iceland, Ireland, Italy, 
Japan, the Netherlands, Portugal, Spain, 
Switzerland, and the UK; one finds that the US has 
much to improve upon in these areas.  In 2006, the 
US spent approximately 15.1% of its GDP on health 
care, more than any other OECD country and 
considerably larger than the 9.0% average of its peer 
nations (OECD Health Data, 2009). This is quite 
negatively juxtaposed with the fact that the US also 
has the lowest female and male life expectancies at 
birth of the same 18 OECD nations. The US female 
life expectancy at birth is 80.7 years (tied with 
Denmark), falling 2.1 years below the average of 82.8 
years; the US male life expectancy at birth is 75.4 
years, again, falling two years below the average of 
77.4 years (OECD Health Data, 2009). This raw and 
partial evidence suggests that the US health care 
system may be performing inefficiently compared to 
its peer nations. 
 
Of course, there are many factors outside of health 
care that effect life expectancy at birth such as 
lifestyle choices regarding the consumption of 
tobacco, alcohol, and non-nutritious foods, pollution 
levels, external causes of death from accidents or 
crime, and socio-economic factors such as GDP per 
capita or average education levels (Joumard, Isabelle 
et al., 2008). It is therefore not accurate to assume 
that inefficient health care is the sole cause of low 
life expectancies in the US without taking these 
other factors into account. For this reason, the 
purpose of my research is to analyze the efficiency of 
the US health care system through a panel data 
analysis of the 19 OECD countries listed above 
(including the US) spanning the years 1990 to 2006 
using an Ordinary Least Squares (OLS) regression of 
a Cobb-Douglas production function. I intend to 
improve upon previous estimates by utilizing the 
most recent data available, including better and 
more specific proxies for certain variables, and only 
including countries whose performance is truly 
comparable to that of the US by removing the low 
performing outliers that fall into a separate 
efficiency and income bracket of their own. 
 
The format of my paper is as follows: Section II 
provides a review of previous literature on the topic 
of health care system efficiency, Section III 
summarizes the theoretical model I employ in my 
research, Section IV outlines my empirical model 
and data, Section V reports my results, Section VI 
offers a summation of my findings and Section VII 
suggests potential venues for further research.  
 
II. Literature Review 
 
Several studies have sought to compare the 
efficiency of health care systems of OECD countries 
in recent years. Most empirical studies have focused 
on assessing and comparing the efficiency of all 
OECD countries without specific attention to the 
relative performance of a particular nation. For this 
reason, most studies include all OECD countries for 
which the desired variables are available over the 
desired period. Looking at the efficiency of all OECD 
nations however, ignores certain biases that may 
skew efficiency results. A recent OECD working 
paper used several measures to analyze the efficiency 
of OECD nations and found that the OECD countries 
could be separated into three different groups based 
on health outcome results. The lowest group 
included the Czech Republic, Hungary, Mexico, 
Poland, the Slovak Republic, and Turkey (Joumard 
et al., 2008). This group had average life 
expectancies at birth that were four to five years 
lower than the average of the second performance 
group and had over seven more infant mortalities 
per 1,000 live births on average than the second 
performance group (Joumard et al., 2008). The 
differences between the second and first 
performance groups were much less extreme with 
differences in average life expectancies of about two 
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years and differences in average infant mortality 
rates of less than one death per 1,000 live births 
(Joumard et al., 2008). My sample will include the 
first two performance groups but will exclude the 
third, along with Korea, in order to create a more 
homogenous group of nations in terms of 
development. This decision will be described further 
in Section IV. 
 
A major matter of debate in health system efficiency 
analysis is what variable is best to use as the output 
of a health care production function. Most studies 
contend that health outcomes are better to use than 
measures of health care activity such as number of 
physician visits, CT scans, etc. (Garber and Skinner, 
2008; Joumard et al., 2008; Or, Wang, and 
Jamison, 2004). Or, Wang and Jamison suggest that 
focusing efficiency analysis on measures of health 
care activity doesn‘t look at the goal of health care, 
which is to improve patient health (2004). It is also a 
general consensus that health care activity analysis 
leads to negative incentives of overuse in health care 
as countries try to increase the quantity of health 
care provided rather than the quality provided. Even 
though it is largely agreed upon that health 
outcomes are a more accurate and appropriate 
measure of health care outputs, the vast array of 
potential measures of health outcomes leads to 
questions of which measure is best to use.  
 
Measures of mortality rates and average life 
expectancies are the most widely available measures 
of overall health outcomes to date. The main 
problem with these measures however is the lack of 
specificity as to the inputs that go into them. As 
mentioned in the introduction, a person‘s life 
expectancy is determined by many factors outside of 
health care such as lifestyle choices, pollution, and 
external causes such as accidents and murder. It is 
difficult to separate these non-health-care-related 
components from the effects of health care. For this 
reason, several studies have looked at specific case 
studies of survival rates after or treatment of specific 
diseases (Preston and Ho, 2009). While these 
measures give good data on the effectiveness of 
specific health care treatments across countries, they 
cannot be expected to provide information on the 
overall efficiency of a health care system (Joumard 
et al., 2008). Therefore, despite the over-
inclusiveness of mortality measures, most studies 
find that they are the best proxies of health outcomes 
currently available (Joumard et al., 2008; Or, Wang, 
and Jamison, 2004). By controlling for as many of 
the non-health-care-related inputs to life expectancy 
as possible, one can ascertain a fairly accurate 
picture of the specific effects of the health care 
industry on patient life expectancy. 
 
The most common control variables for non-health-
care-related inputs used in recent studies have been 
tobacco and/or alcohol use, diet, pollution, 
education levels, and GDP (Joumard et al., 2008; 
Or, Wang, and Jamison, 2004). A problem area with 
recent studies is their choice of proxies used for diet 
and exercise. Or, Wang, and Jamison completely 
neglected this variable in their study (2004) and 
Joumard et al. used the number of fruits and 
vegetables consumed as a proxy for diet and exercise 
(2008). This proxy, however, does not actually 
account for exercise and they had problems with the 
significance and robustness of the variable due to 
time lag issues. A person‘s diet now is likely to have 
stronger effects on her future health than it does on 
her current health. An overweight and diabetic 
individual who has consumed unhealthy foods and 
exercised little throughout her life but has recently 
began to improve her diet through the increased 
consumption of fruits and vegetables is unlikely to 
see a change in her health status for some time. 
Simply measuring the consumption of fruit and 
vegetables does not account for these lagged effects. 
Obesity is a much better proxy for diet and exercise 
since it measures the current negative health effects 
of an extended period of poor diet and exercise.  
 
Obesity has not been used in previous studies due to 
data availability, primarily because of differences in 
measurement techniques. Some countries use survey 
data to measure individuals‘ body mass index (BMI) 
while others use actual measures of individuals‘ 
height and weight creating differences in obesity 
rates across countries (OECD 2009 Health Data). It 
is hypothesized that countries using actual measures 
of height and weight have higher obesity rates than 
countries in which survey data is used since people 
are likely to underestimate, intentionally or not, 
their weight when asked. Of the countries included 
in my study, Australia, Japan, the UK, and the US 
use actual measures of height and weight rather than 
survey data (OECD 2009 Health Data). While 
Australia, the UK, and the US have higher obesity 
rates than the other peer nations, Japan has the 
lowest rates of the OECD nations, suggesting that 
the bias may be less extreme than is hypothesized. 
Also, since I am estimating the efficiency of health 
care in the US specifically, and since the US has the 
highest obesity rates of all of the countries in my 
analysis, the efficiency estimates of the US would 
most likely be biased upwards if the obesity data of 
other nations is truly inaccurate and biased 
downwards. This is because the US will experience a 
larger negative impact on health outcomes due to 
obesity, thus reducing the negative impact to be 
absorbed by health care inefficiency. Because most 
studies have found that the US lies on the low side of 
efficiency rankings compared to other OECD 
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countries (Garber and Skinner, 2008; Joumard et 
al., 2008; Or, Wang, and Jamison, 2004), including 
obesity as a control variable would only help the US 
in its efficiency estimates. I therefore use obesity 
rates in my analysis despite these differences in 
measurements. 
 
Studies vary in their choices of medical inputs as 
well. Most use either the number of physicians, 
hospital beds, or CT scanners as physical measures 
of inputs or use total, public, or private health 
expenditure as monetary measures of inputs, but few 
have used both physical and monetary measures 
simultaneously. Physical and monetary input 
measures are generally seen as substitute proxies for 
health care inputs. For example, Wang, Jamison, 
and Or used the number of practicing physicians per 
1,000 people because they did not feel that adequate 
measures of health expenditure were available 
(2004). Joumard et al. ran separate regressions 
using the number of practicing physicians in one set 
of regressions and total health expenditure in the 
other set (2008). Joumard et al. claim that increases 
in total health expenditure leads to more practicing 
physicians but I feel that this assumption only holds 
under the assumption that the wages paid to 
physicians are equal across countries, which is not 
the case. An increase in total expenditure of 155,000 
US$ would buy Germany two more physicians while 
it would not even pay for one extra physician in the 
United States according to the average physician 
incomes reported by Garber and Skinner from the 
OECD 2007 Health Data (2008). I therefore believe 
that it would be acceptable to use the number of 
practicing physicians as a proxy for labor inputs and 
total health expenditure as a proxy for other health 
care inputs as well as the emphasis placed on 
healthcare by each country.
 
III. Theory  
I use a Cobb-Douglas production function in my 
research to analyze the efficiency of the US health 
care system compared to its peer nations. A 
production function allows me to, in theory, asses 
the efficiency with which a nation uses its health care 
inputs to produce an optimal level of health output. 
A Cobb-Douglas production function is of the 
generic form 
 
 
 
where Y represents output, L represents labor 
inputs, K represents capital inputs, and A is a 
technological parameter. In the context of health 
care efficiency, the theoretical model that I regress is 
 
Health Outcomes = α(L)β1(K)β2(socioeconomic)β3 
(lifestyle)β4 
 
 
where   include income 
levels and equality, institutional parameters, and 
education and  include tobacco 
and alcohol use, diet, and exercise. Representing 
 as HO,  as 
SC, and  as LC, and transposing 
the equation into log linear form for the sake of 
running an OLS regression, I have 
 
 
 
where εit is the error term of country i in time t. 
 
IV. Empirical Model 
 
My data come from the OECD 2009 Health Data set. 
I use cross-sectional data analyzed over time and 
include dummy variables for each country in order to 
absorb the country effects which are otherwise 
unaccounted for in my model. The 19 OECD 
countries I analyze are Australia, Austria, Belgium, 
Canada, Denmark, Finland, France, Germany, 
Greece, Iceland, Ireland, Italy, Japan, the 
Netherlands, Portugal, Spain, Switzerland, the United 
Kingdom, and the United States. I chose to eliminate 
the six  
 
 
countries mentioned in Section II as being in the 
lowest performance group among the OECD nations, 
along with Korea, from my analysis due to their GDP 
per capita income levels which were all below 20,000 
US$ in 2007(OECD 2009 Health Data). The average 
GDP per capita of the 19 OECD countries I have 
chosen to analyze was a little under 44,000 US$ in 
2007 (OECD 2009Health Data). It does not seem 
accurate to include nations with less than half of the 
income level of the average of the other countries in 
the analysis. Furthermore, the GDP per capita of the 
US in 2007 was a little over $45,000, implying that 
removing these lower income nations creates a less 
biased cross country comparison of the efficiency of 
the United States compared to its peer nations. 
Because of the income levels of these seven nations 
and further because of the findings in the OECD 
working paper cited in Section II, the Czech Republic, 
Hungary, Mexico, Poland, the Slovak Republic, 
Turkey, and Korea will excluded from my 
comparative analysis. 
The Park Place Economist, Volume XVIII 12 
 
In the case of holes in data availability, I assume that 
the change from one available point to the next is 
linear which is generally evinced through the 
adjacent, complete strings of data. In a few instances, 
I continue to increase or decrease variables beyond 
the given endpoints following the same linear pattern 
of the preceding data points. To extend the endpoints 
of strings of data that are otherwise fully complete, I 
run regressions of the variable against time to find 
the average increase or decrease in the variable per 
year, and fill in the missing data accordingly. 
 
As a proxy for health outcomes, I run separate 
regressions using the average life expectancies of men 
and women at birth and at age 60 since a large 
portion of health expenditure is spent on senior 
citizens (Joumard et al., 2008). The OECD 2009 
Health Data includes a unique measure of potential 
life years lost which weights deaths of younger 
individuals higher than those of older individuals. 
Included in these measures is potential life years lost 
due to external causes which includes deaths from 
accidents and murder. As suggested by Joumard et 
al., I obtain a measure for potential life years lost due 
to health related issues by subtracting potential life 
years lost due to external causes from potential life 
years lost from all causes. This removes a small 
amount of bias in the health outcome measure used. 
To further reduce the bias of non-health-care related 
variables, I include several control variables that 
account for outside effects on health outcomes. 
 
As socio-economic controls, I include GDP per capita 
which has been found to be significant in previous 
studies. Unfortunately, due to data availability, I am 
unable to include a proxy for educational attainment 
which has also been found to be significant in 
previous studies. I do not include parameters for 
institutional differences because it is too difficult to 
disentangle the combinations of institutional 
frameworks enacted by individual countries 
(Joumard et al., 2008). As lifestyle controls, I include 
the percentage of the population over age 15 who 
smoke daily, alcohol consumption in liters per capita, 
and the percentage of the population that is obese. I 
use the number of practicing physicians as well as the 
total expenditure on health as measures of health 
care inputs for the reasons stated in the literature 
review. I also run a slightly more limited regression 
removing Japan due to data unavailability, using the 
number of practicing general practitioners in the 
place of the number of practicing physicians. I do this 
because of the growing international concerns that 
there will be shortages of general practitioners in the 
near future. I also feel that the ratio of general 
practitioners to specialists contributes significantly to 
improving the health outcomes as well as the cost 
effectiveness of a health care system. 
 
My empirical model is shown below along with Table 
1 which provides the descriptive statistics of my 
dependent and independent variables. 
 
 
lnLEit = α + β1 ln Physit + β2 ln HealthExpit + β3 ln 
Tobit + β4 ln Alcit + β5 ln Obeseit + β6 ln GDPit + 
β7CountryDummy + εit 
 
For the variable Phys I run separate regressions using 
both the total number of practicing physicians and 
the number of practicing general practitioners. 
Likewise, for the variable HealthExp I run separate 
regressions using both total health expenditure per 
capita and total health expenditure as a percentage of 
GDP. CountryDummy represents separate dummy 
variables for each country with the US as the 
excluded case. The coefficients of these dummy 
variables will give me an indication of the 
performance of the other peer nations, relative to that 
of the US, holding the effects of the other variables 
constant. The brunt of my analysis will be formed 
from the values of these coefficients. 
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 Table 1: Descriptive Statistics 
Variable Description N Min Max Mean Std. Deviation 
Dependent Variables      
LEFbirth Life expectancy of females at birth 
(Years) 
367 77 86 80.93 1.699 
LEMbirth Life expectancy of males at birth 
(Years) 
367 70 80 74.93 1.980 
LEF60 Life expectancy of females at age 60 
(Years) 
363 20 28 23.75 1.376 
LEM60 Life expectancy of males at age 60 
(Years) 
363 17 23 19.58 1.332 
PotLifeLostMed Potential years of life lost minus 
those due to external causes 
(years per 100,000 people 0-69) 
353 1679 5220 3111.15 655.622 
Independent Variables      
HealthExpGDP 
(+ LE, - PLL) 
Total expenditure on health   
(% of GDP) 
362 5 15 8.42 1.734 
HealthExpCap 
(+ LE, - PLL) 
Total expenditure on health per capita  
(US$ exchange rate) 
376 341 7290 2368.10 1216.764 
GDP 
(+ LE, - PLL) 
GDP per capita  
(US$ exchange rate) 
380 5398 64135 26225.46 10166.138 
Alcohol 
(- LE, + PLL) 
Alcohol consumption of those 15+  
(liters per capita) 
354 5 16 10.61 2.369 
Tobacco 
(- LE, + PLL) 
Tobacco consumption of those 15+  
(% of population who smoke daily) 
352 15 45 27.44 5.897 
Obese 
(- LE, + PLL) 
Body weight and composition 
(% of population who are obese) 
291 2 34 12.12 6.190 
GenPract 
(+ LE, - PLL) 
Practicing General Practitioners 
(Density per 1,000 people) 
303 0 2 1.02 .499 
TotalPhys 
(+ LE, - PLL) 
Practicing Physicians 
(Density per 1,000 people) 
345 2 12 2.93 .855 
 
V. Results 
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As is shown by Table 2, the US spends a larger 
portion on health care as a percentage of GDP than 
the mean of its peer nations by over one and a half 
times throughout the period of regression. High 
health expenditure in the US is accompanied by a 
lower mean number of practicing general  
practitioners and total physicians, lower mean life 
expectancies, as well as more mean potential life  
years lost than the means of its peer nations.  The 
areas in which the US has a more favorable mean 
over the period than its peer nations is in the use of 
alcohol and tobacco while the mean obesity rate of 
the US relative to its peer nations is over twice as 
large. In combination, these raw data  
suggest that the US performs less efficiently than its 
peer nations over the period of regression.  
 
The strongest models in my regression include total 
health expenditure as a percentage of GDP rather  
 
 
than total health expenditure in per capita terms. 
This is because including lnHealthExpCap made 
lnGDP insignificant and because lnHealthExpCap 
and lnGDP have a Pearson Correlation of .951 that is 
significant at the .01 level while lnHealthExpGDP and 
lnGDP have a Pearson Correlation of only .521 
though it is still significant at the .01 level. I also 
exclude Obese because it is found to be insignificant 
and to have the wrong sign, implying that an increase 
in obesity leads to an increase in life expectancy and a 
decrease in potential life years lost. This is likely due 
to the poor quality of the data and removing this 
variable seems to be the appropriate decision to 
improve the model. Table 3 displays the results of the 
five separate dependent variables regressed against 
lnTotalPhys.  
 
Almost all coefficients are significant at the .001 level 
and all have the expected signs. The adjusted R2 
values are all between 86.5% and 91.9% suggesting a 
good fit of the data. While all of the coefficients are 
significant, some are larger than others. It is 
important to note that the mean value of potential life 
years lost due to medical or health related causes in 
the nations included in the regression is 3,111.15 years 
per 100,000 people. Thus, coefficients of the 
independent variables regressed against 
lnPotLifeLostMed are expected to be larger than 
those regressed against life expectancy. The results 
consistently suggest that decreasing smoking has the 
largest positive effect on health outcomes while 
increasing the number of total practicing physicians 
has the smallest positive impact on health outcomes.   
 
The coefficients of the country dummy variables are 
of extreme importance in the model. These 
coefficients show the difference in health outcomes 
between a given country relative to that of the US 
holding all other effects in the model constant. All of 
the country coefficients are significant at the .001 
level and all have signs suggesting better health 
outputs than that of the US. The largest positive 
difference is almost always held by Japan with the 
exception of male life expectancy both at birth and at 
age 60 in which Japan has the second and third 
highest difference from that of the US respectively. 
The country with the smallest difference from the US 
varies from measure to measure with the smallest 
overall difference being a higher female life 
expectancy at birth in Denmark of .031 years or about 
4 months holding all else constant. The main issue in 
interpretation of the country coefficients is that it is 
impossible to tell what each coefficient is picking up. 
The difference cannot be entirely attributed to 
inefficiency, particularly since measures for obesity, 
pollution levels and education rates which are likely 
to have significant effects on health outputs are not 
included. 
 
 
 
 
Table 3: Regression Results Including lnTotalPhys as an Independent Variable 
 lnPotLifeLostMed lnLEFbirth lnLEF60 lnLEMbirth lnLEM60 
 
(Constant) 8.562*** 4.264*** 2.815*** 4.190*** 2.485*** 
LnHealthExpGDP -.288*** .026*** .051** .033*** .088*** 
LnGDP -.163*** .019*** .057*** .028*** .085*** 
Table 2: Comparison of Means: 
US vs. Peer Nations 
 Peer Nations US 
HealthExpGDP 8.136 13.215 
GDP 25927.66 31585.85 
Alcohol 10.725 8.558 
Tobacco 27.867 20.275 
Obese 11.147 28.838 
GenPract 1.0286 .9253 
TotalPhys 2.9544 2.2980 
LEFbirth 81.010 79.395 
LEMbirth 75.011 73.384 
LEF60 23.780 23.205 
LEM60 19.585 19.500 
PotLifeLostMed 3061.10 4042.56 
The Park Place Economist, Volume XVIII 15 
LnTobacco .577*** -.040*** -.100*** -.071*** -.172*** 
LnAlcohol .256*** -.021*** -.056*** -.037*** -.073*** 
LnTotalPhys -.132*** .012*** .031*** .020*** .055*** 
AUS -.709*** .056*** .117*** .075*** .144*** 
AUSL -.656*** .047*** .085*** .061*** .096*** 
BELG -.648*** .049*** .101*** .060*** .096*** 
CAND -.583*** .049*** .104*** .065*** .124*** 
DEN -.649*** .031*** .039*** .065*** .084*** 
FIN -.661*** .046*** .079*** .039*** .059*** 
FRAN -.638*** .070*** .170*** .068*** .155*** 
GERM -.478*** .037*** .062*** .046*** .057*** 
GRE -.970*** .069*** .132*** .114*** .254*** 
ICE -.711*** .036*** .049*** .061*** .099*** 
IRE -.838*** .051*** .078*** .085*** .126*** 
ITALY -.630*** .063*** .127*** .074*** .131*** 
Table 3 Continued 
JAPAN -1.066*** .098*** .223*** .109*** .224*** 
NETH -.774*** .055*** .107*** .085*** .124*** 
PORT -.339*** .042*** .085*** .044*** .107*** 
SPAIN -.907*** .092*** .206*** .107*** .243*** 
SWITZ -.665*** .057*** .122*** .070*** .120*** 
UK -.685*** .048*** .081*** .083*** .137*** 
 R2 .906 .919 .913 .879 .865 
*** significant at the .001 level ** significant at the .01 level 
 
Upon replacing the independent variable lnTotalPhys 
with lnGenPract some interesting results are found. 
Table 4 displays these results. Due to data availability 
of the number of practicing general practitioners, 
Japan has been removed from this series of 
regressions. 
 
 
Table 4: Regression Results Including lnGenPract as an Independent Variable 
 lnPotLifeLostMed lnLEFbirth lnLEF60 lnLEMbirth lnLEM60 
 
(Constant) 8.606*** 4.252*** 2.777*** 4.163*** 2.431*** 
LnHealthExpGDP -.379*** .031*** .064** .053*** .134*** 
LnGDP -.166*** .020*** .061*** .029*** .086*** 
LnTobacco .569*** -.037*** -.091*** -.067*** -.163*** 
LnAlcohol .314*** -.026*** -.073*** -.047*** -.096*** 
LnGenPract -.172 .025** .058* .041*** .121*** 
AUS -.719*** .052*** .108*** .074*** .134*** 
AUSL -.688*** .045*** .084*** .062*** .091*** 
BELG -.636*** .038*** .079** .048*** .052 
CAND -.586*** .047*** .099*** .065*** .122*** 
DEN -.779*** .043*** .068*** .091*** .152*** 
FIN -.764*** .056*** .102*** .062*** .118*** 
FRAN -.646*** .064*** .159*** .063*** .130*** 
GERM -.482*** .031*** .051** .041*** .037 
GRE -1.337*** .108*** .220*** .180*** .440*** 
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ICE -.837*** .048*** .078*** .086*** .168*** 
IRE -1.062*** .075*** .138*** .133*** .256*** 
ITALY -.737*** .071*** .148*** .095*** .183*** 
NETH -.986*** .078*** .162*** .131*** .249*** 
PORT -.363*** .038*** .082*** .043*** .094** 
SPAIN -.989*** .094*** .210*** .121*** .266*** 
SWITZ -.893*** .084*** .185*** .118*** .255*** 
UK -.799*** .059*** .108*** .110*** .207*** 
R2 .896 .893 .884 .882 .863 
*** significant at the .001 level ** significant at the .01 level * significant at the .02 level 
 
 
The coefficient to the number of practicing general 
practitioners is not found to be statistically significant 
when regressed against potential life years lost due to 
medical or health related causes and the adjusted R2 
value decreases for most of the new regressions. 
However, the values of the adjusted R2 terms are all 
still between 86.3% and 89.3% suggesting good 
overall explanatory power. Furthermore, the 
coefficients for lnGenPract are all still significant at 
the .02 level or lower when regressed against the 
measures of life expectancy. Table 5 shows the 
important difference in the values of the coefficients 
for lnTotalPhys versus lnGenPract. While the 
significance level of the coefficients for lnGenPract is 
generally smaller, the size of the coefficients 
regressed against various measures of life expectancy 
are approximately twice that of the coefficients for 
lnTotalPhys. This implies that increasing the number 
of practicing general practitioners could have a 
stronger positive impact on life expectancy than 
increasing the total number of practicing physicians 
without regard to their field of practice. There were 
slight increases and decreases in the coefficients of 
the other variables, but none of the differences were 
as large as the change in effect of the number of 
physicians. 
 
 
Table 5: Coefficients for lnTotalPhys and lnGenPract 
lnPotLifeLostMed          lnLEFbirth lnLEF60 lnLEF60 lnLEM60 
TotPhys GenPract TotalPhys GenPract TotalPhys GenPract TotalPhys GenPract TotalPhys GenPract 
-.132*** -.172 .012*** .025** .031*** .058* .020*** .041*** .055*** .121*** 
*** significant at the .001 level  ** significant at the .01 level  * significant at the .02 level 
 
 
The explanation of the country dummy coefficients 
when lnGenPract is included is similar to the results 
found in the previous regressions The country 
coefficients regressed against measures of life 
expectancy and potential life years lost are again 
mostly significant at the .001 level and have signs 
suggesting that each peer nation has better health 
outcomes than that of the US holding all other effects 
constant. The exception is in the life expectancy of 
males at age 60 in which the coefficients for Belgium 
and Germany are found to be insignificant meaning 
that, holding the other effects of the model constant, 
Belgium and Germany do not experience significantly 
higher life expectancies for males at age 60 than that 
of the US. 
 
 
 
VI. Conclusion 
 
As a whole, the regressions explain a large portion of 
the variation in health outcomes, as measured by life 
expectancy and potential life years lost, among the 
OECD nations studied. The findings suggest that, 
holding other effects constant, the US experiences 
worse health outcomes than its peer nations. The 
number of practicing general practitioners is found to 
have approximately two times the positive effect on 
life expectancy than the number of total practicing 
physicians has, suggesting that increasing the 
number of general practitioners relative to specialists 
would have a positive effect on health outcomes. 
Smoking is found to have the largest impact on health 
outcomes suggesting that smoking may outweigh the 
positive effects of health care. The policy implications 
of these results are often considered unappealing in 
the political world as they involve increasing 
government regulation and programs in health care. 
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If these results are correct, then the US needs to 
seriously analyze its productive efficiency in health 
care relative to that of other nations. It is likely that a 
change in the system to one that is more generally 
followed in other nations may be appropriate. While 
obesity, pollution, and education levels are 
unaccounted for in my model, the variables that are 
accounted for do not absorb enough of the negative 
health outcomes experienced by the US relative to its 
peers to remove the blame from an inefficient health 
care system. It also seems that it would be beneficial 
for all nations to create incentives for medical 
students to choose careers as general practitioners 
rather than specialists which may mean alterations in 
the salary levels of specialists relative to those of 
general practitioners. The models also show that the 
negative effects of smoking greatly decrease health 
outcomes, even when taking health care factors into 
consideration. This implies that stricter regulation on 
the contents of tobacco products as well as the ease of 
purchase of these products may be necessary to 
improve the health outcomes of a nation. The 
significance levels of my variables as well as the R2 
values of the models suggest that this information is 
at least headed in an appropriate and accurate 
direction. 
 
VI. Venues for Further Research 
 
Significance levels and R2 values aside, there is much 
room for improvement to be had in the regression 
models and analysis used here. Main data issues 
involve the lack of available proxies for obesity, 
pollution, and education levels. Taking these 
variables into account explains more of the variation 
in health outcomes, which will likely reduce the size 
and possibly the significance of the country 
coefficients. Including measures for these factors will 
thus offer a better approximation of the differences in 
health outcome due to the inefficiency of a country‘s 
health care system rather than the socio-economic 
differences among nations. It has also been shown 
effective in previous studies to analyze the residuals 
of the regressions along with specific country effects 
in order to get a better approximation for inefficiency 
which often involves rather advanced econometric 
techniques. I would also like to check my models for 
the typical model errors such as multicollinearity, 
autocorrelation, and heteroscedasticity. I feel that, in 
finding additional proxies for socio-economic and 
lifestyle factors, increasing the econometric level of 
my analysis and addressing potential issues in the 
models, I can create stronger results that will 
continue to support the current findings of my 
research. 
REFERENCES 
Docteur, E., Suppanz, H., & Woo, J. (2003). The US 
health system: An assessment and prospective 
directions for reform. OECD Economics Department, 
OECD Economics Department Working Papers). 
http://www.sourceoecd.org/10.1787/768340075526 
Retrieved from EconLit database.  
 
Epperly, T. (2008). Commentary: Why we do need more 
doctors. CNN.Com, Retrieved from 
http://www.cnn.com/2009/HEALTH/05/27/epperly
.doctors/index.html?iref=newssearch  
 
Garber, A. M., & Skinner, J. (2008). Symposium: Health 
care: Is American health care uniquely inefficient? 
Journal of Economic Perspectives, 22(4), 27-50. 
doi:10.1257/jep.22.4.27  
 
Jacobs, R., Smith, P. C., & Street, A. (2006). Measuring 
efficiency in health care: Analytic techniques and 
health policy. Cambridge and New York: Cambridge 
University Press. Retrieved from EconLit  
 
Joumard, I., Andre, C., Nicq, C., & Chatal, O. (2008). 
Health status determinants: Lifestyle, environment, 
health care resources and efficiency. OECD 
Economics Department, OECD Economics 
Department Working Papers). 
http://www.sourceoecd.org/10.1787/240858500130 
Retrieved from EconLit database.  
 
OECD health data 2009: Statistics and indicators for 
30 countries Retrieved 10/30/2009, 2009, from 
http://www.oecd.org/document/30/0,3343,en_2649
_34631_12968734_1_1_1_37407,00.html 
 
Or, Z., Wang, J., & Jamison, D. (2005). International 
differences in the impact of doctors on health: A 
multilevel analysis of OECD countries. Journal of 
Health Economics, 24(3), 531-560. 
doi:10.1016/j.jhealeco.2004.09.003  
 
Simoens, S., & Giuffrida, A. (2004). The impact of 
physician payment methods on raising the efficiency 
of the healthcare system: An international 
comparison. Applied Health Economics and Health 
Policy, 3(1), 39-46. Retrieved from 
http://pt.wkhealth.com/pt/re/ahe/home.htm;jsessio
nid=GLcpn16FyjFlQLL3QnzvLNLnmWGNhpGQx61p
NwsvRVgqJhth3TDQ!-818462210!-
949856145!8091!-1  
 
 
 
 
